Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05112601
Title Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

endometrial cancer

Therapies

Ipilimumab + Nivolumab

Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of New Mexico Cancer Center Recruiting Albuquerque New Mexico 87102 United States Details
University of Oklahoma Health Sciences Center Recruiting Oklahoma City Oklahoma 73104 United States Details
NRG Oncology Recruiting Philadelphia Pennsylvania 19103 United States Details
University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh Pennsylvania 15232 United States Details
Women and Infants Hospital Recruiting Providence Rhode Island 02905 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field